Abstract
ONE of the many properties of prostaglandin E1 (PGE1) is that it inhibits the aggregation of blood platelets in plasma at µg/ml. platelet-rich plasma1–3, and of ADP-induced adhesiveness at the same low concentration1,2. Emmons et al.1 have also shown that platelet plug formation is prevented in vivo during infusion of PGE1. Because of this we decided to investigate the effect of PGE1 on clot retraction.
Access options
Subscribe to Journal
Get full journal access for 1 year
220,50 €
only 4,32 € per issue
All prices include VAT for France.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
Emmons, P. R., Hampton, J. R., Harrison, M. J. G., Honour, A. J., and Mitchell, J. R. A., Brit. Med. J., 2, 468 (1968).
- 2.
Kloeze, J., Nobel Symp. Prostaglandins (edit. by Bergström, S. and Samuelsson, B.), 241 (Almquist and Wiksell, Stockholm, 1967).
- 3.
Irion, E., and Blombäck, M., Scand. J. Clin. Lab. Invest., 24, 141 (1969).
- 4.
Blombäck, B., and Blombäck, M., Arkiv för Kemi, 10, 415 (1956).
- 5.
Solum, N. O., Scand. J. Clin. Lab. Invest., 18, 577 (1966).
Author information
Affiliations
Institute for Thrombosis Research, Rikshospitalet, University of Oslo
- E. H. MÜRER
Authors
Search for E. H. MÜRER in:
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.
About this article
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
